News

top diabetes news, camel milk, diabetes

Top Diabetes News of Today

Camel milk could be used to lower inflammation in type 2 diabetes

BY JACK WOODFIELD: Camel milk could be used to reduce inflammation in people with type 2 diabetes, Welsh researchers have suggested.

Cardiff Metropolitan University scientists have explored the health benefits of the milk, which has previously been linked with a reduced risk of developing type 2 diabetes.

Camel milk is very nutritious, and milk fat is an important component due to its high nutritional value. The researchers were keen to use camel milk in this study because it has a higher level of polyunsaturated fat than cow’s milk. However, because of the complexity of camel milk’s makeup, the researchers only decided to only evaluate its effect on inflammation.  (read more)

Research reviews effectiveness of bariatric surgery for adolescents

BY BENEDICT JEPHCOTE: American researchers have assessed the benefits of bariatric surgery for obese adolescents and found it may represent an effective treatment under the right circumstances.

A team from Rutgers University looked into the justifiability of the procedure for teenagers as pediatricians have been cautious about recommending the surgery in the young. The reviews gathered evidence that can help healthcare professionals make an informed choice. (read more)

New U.S. diabetes cases fall, even as obesity rates rise

BY ASSOCIATED PRESS: The number of new diabetes cases among U.S. adults keeps falling, even as obesity rates climb, and health officials aren’t sure why.

New federal data released Tuesday found the number of new diabetes diagnoses fell to about 1.3 million in 2017, down from 1.7 million in 2009.

Earlier research had spotted a decline, and the new report shows it’s been going on for close to a decade. But health officials are not celebrating. (read more)

A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why  

BY ELIE DOLGIN: The first two rounds of treatment went off without a hitch. But last November, after receiving a third dose of potent immunotherapy for his skin cancer, Rich Lenihan started to feel tired and weak.

He was urinating constantly, and no amount of water could abate his thirst. A blood test revealed glucose levels that were through the roof.

Lenihan, at age 62, had developed a disease akin to type 1 diabetes — formerly called “juvenile” diabetes — a rare complication of drugs known as checkpoint inhibitors that rev up the body’s immune assault on tumor tissue. (read more)

FDA approves new treatment for diabetic condition that can lead to blindness 

BY GINGER VIEIRA: Diabetic retinopathy is the leading cause of blindness in adults across the globe, according to the American Journal of Managed Care.

The most challenging aspect of retinopathy is that it often goes undetected until too much damage has been done and the person affected is already losing their vision.

As a result, this nearly silent assault on the eyes leaves people living with diabetes with few treatment options as the severity of the condition and vision loss worsens.

However, a new treatment option — Eylea, from Regeneron Pharmaceuticals — has just been approved by the Food and Drug Administration (FDA) to treat all stages of diabetic retinopathy. (read more)